e-learning
resources
Milan 2017
Wednesday, 13.09.2017
The acute patient: the clinical point-of-view
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung attacks in the ED: measurements to predict outcome. The AWARD study.
R. Russell (Lymington, United Kingdom)
Source:
International Congress 2017 – The acute patient: the clinical point-of-view
Session:
The acute patient: the clinical point-of-view
Session type:
Poster Discussion
Number:
4750
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Russell (Lymington, United Kingdom). Lung attacks in the ED: measurements to predict outcome. The AWARD study.. 4750
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Differences in acute response team call triggering with CREWS scoring: A retrospective analysis
Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning
Year: 2015
Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Observational study to characterise 24-hour COPD symptoms: Interim analysis of ASSESS
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013
COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
Late Breaking Abstract - Lung ultrasound for severity assessment and outcome prediction of COVID-19 patients.
Source: Virtual Congress 2020 – Transthoracic and endobronchial ultrasound
Year: 2020
Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Value of measuring SGRQ at stable phase of COPD to predict the timing and deterioration associated with next exacerbation: the MOSAIC study
Source: Eur Respir J 2004; 24: Suppl. 48, 240s
Year: 2004
Preliminary outcomes of the CREWS study
Source: International Congress 2015 – Best abstracts in chronic care
Year: 2015
Mometasone/indacaterol/glycopyrronium (MF/IND/GLY) improves lung function and reduces exacerbations in patients with asthma, independent of baseline airflow limitation: Results from IRIDIUM study
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021
Late Breaking Abstract - Optimizing FEV1/FVC threshold to predict COPD hospitalization and mortality: NHLBI pooled cohorts study
Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD?
Year: 2018
Data from the PROGRESS study - blood gene expression patterns predict severe outcome of community aqcuired pneumonia
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018
LATE-BREAKING ABSTRACT: Predictors of lung function decline in a cohort of subjects with severe asthma
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015
COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study
Source: International Congress 2014 – Markers
Year: 2014
Respiratory parameters predict mortality in COPD patients - data from the Czech multicentre research database of severe COPD.
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Indacaterol/glycopyrronium (IND/GLY) improves lung function irrespective of gender baseline differences in patients with COPD: A pooled analysis from the IGNITE Program
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016
Childhood asthma attack: a study of the clinical and spirometrical severity criteria during admission in an emergency unit
Source: Annual Congress 2007 - Assessing asthma severity and control in children
Year: 2007
Baseline characteristics of patients admitted for the first time for COPD exacerbation. The ²phenotype and course of COPD² (PAC-COPD) study
Source: Annual Congress 2007 - Epidemiology of COPD
Year: 2007
Changes in functional respiratory imaging (FRI) endpoints correlate with changes in patient reported outcomes (PRO) after recovering from acute COPD exacerbation
Source: International Congress 2015 – Functional imaging approaches for evaluating alteration of lung, airways and respiratory muscles
Year: 2015
Who win? Spirometry versus symptoms for predicting the longitudinal outcomes in COPD patients – 10 years observation
Source: Annual Congress 2011 - Clinical parameters in airway diseases
Year: 2011
Indacaterol/glycopyrronium (IND/GLY) reduces the risk of clinically important deterioration (CID) in patients with moderate COPD: Results from the CRYSTAL study
Source: International Congress 2017 – Bronchodilators and bronchoprotectors
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept